0.87% -0.0063

Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie

Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie

Phio Pharmaceuticals expands incentive plan following shareholder approval By Investing.com - Investing.com Canada

Phio Pharmaceuticals expands incentive plan following shareholder approval - Investing.com India

Phio Pharmaceuticals expands incentive plan following shareholder approval By Investing.com - Investing.com Australia

Phio Pharmaceuticals expands incentive plan following shareholder approval - Investing.com South Africa

Phio Pharmaceuticals expands incentive plan following shareholder approval By Investing.com - Investing.com

Scotiabank ups Millicom International Cellular shares target on strong cash flow By Investing.com - Investing.com

Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying - MSN

HireQuest CEO buys company shares worth $575 By Investing.com - Investing.com Australia

What technical indicators reveal about PHIO stock – US Post News - US Post News

Recent Insider Activity Could Benefit Phio Pharmaceuticals Corp (PHIO) – Knox Daily - Knox Daily

Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - The Intelligencer

Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - Shoreline Beacon

Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - StockTitan

Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying - Phio Pharma (NASDAQ:PHIO) - Benzinga

Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying - Phio Pharma (NASDAQ:PHIO) - Benzinga

Phio Pharmaceuticals CEO buys $740 in company stock By Investing.com - Investing.com

Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying - Alset (NASDAQ:AEI) - Benzinga

Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying - Alset (NASDAQ:AEI) - Benzinga

Phio pharmaceuticals CEO buys $750 worth of company stock - Investing.com India

Phio pharmaceuticals CEO buys $750 worth of company stock By Investing.com - Investing.com

Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 2.5% - Defense World

Market Momentum Report: Phio Pharmaceuticals Corp (PHIO)'s Positive Close at 0.75 – DWinneX - The Dwinnex

Goldman Sachs neutral on GlaxoSmithKline stock By Investing.com - Investing.com

Phio Pharmaceuticals advances to next dose in cancer trial By Investing.com - Investing.com

Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b ... - Yahoo Finance

Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b ... - Newsfile

Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology ... - Yahoo Finance

Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology ... - Yahoo Finance

Phio Pharmaceuticals secures investment from TRITON Funds By Investing.com - Investing.com

Phio Pharmaceuticals Secures New Investor - GlobeNewswire

Phio Pharmaceuticals Secures New Investor

FY2024 EPS Estimates for Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Boosted by HC Wainwright - Defense World

Phio Pharmaceuticals Secures New Investor - Yahoo Finance

Phio Pharmaceuticals' (PHIO) Buy Rating Reiterated at HC Wainwright - Defense World

Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) - GlobeNewswire

Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) - Yahoo Finance

Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) - GlobeNewswire

Phio Pharmaceuticals Corp. Forecasted to Post Q2 2024 Earnings of ($0.51) Per Share (NASDAQ:PHIO) - Defense World

Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation ... - GlobeNewswire

Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation ... - Yahoo Finance

Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation ... - GlobeNewswire

KalVista (KALV) Stock Continues to Decline: Here's Why - Yahoo Singapore News

Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update - GlobeNewswire

Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update

Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update - Yahoo Finance

Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)

Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology ... - Yahoo Finance

ServiceNow stock target cut $20, retains Outperform rating By Investing.com - Investing.com

Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells

Intratumoral Injection of Phio's PH-762 significantly - GlobeNewswire

Simile a PHIO